Stool DNA test for colorectal cancer screening in Lynch syndrome
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a stool-based DNA test for people with Lynch syndrome. It aims to find colorectal cancer early by checking stool samples for specific DNA changes, so you can catch problems sooner and get the right care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of Lynch syndrome, a genetic condition that raises the risk of colorectal cancer.
- You agree to provide stool samples for a special DNA test (methylation sequencing) that looks for early warning signs.
- You are willing to have long-term follow-up and three rounds of screening with this stool test.
- You cannot have other inherited colorectal cancer conditions like familial adenomatous polyposis (FAP).
- You are not currently being treated for colorectal cancer or having surgery for it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and stool samples to see how well they can detect colorectal cancer or advanced growths in people with Lynch syndrome (an inherited colon cancer risk) or suspected Lynch syndrome. It may help find cancer or precancer earlier, which can improve next-step decisions.
This study checks tumor samples from people having surgery for colorectal cancer to look for a genetic condition called Lynch syndrome, which can increase the risk of other cancers. Finding it early can help you and your family take steps to protect your health.
This study is testing whether a simple blood test can safely replace some of the more invasive procedures used to monitor people with Lynch syndrome, a condition that increases the risk of certain cancers (especially colorectal and uterine). If the blood test works as well, it could mean fewer colonoscopies and other invasive tests for those with Lynch syndrome.
This study tests a special CAD-EYE system to help detect abnormal (potentially cancer-related) growths during colonoscopy in people with Lynch syndrome. It may improve how reliably clinicians find lesions early, when treatment can be easier.
This registry study looks at how many people with colon cancer also have Lynch syndrome, an inherited condition that can affect cancer risk. If you enroll, your care team collects basic information from your diagnosis to better estimate how common it is.
This study looks at whether certain risk scores and universal tumor screening can help identify people with Lynch syndrome, a genetic condition that raises the risk of colorectal and other cancers. By participating, you may learn more about your genetic risk, which can guide future cancer screening and prevention.
Hear when a new Colorectal Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.